» Articles » PMID: 19617347

Characterization of YafO, an Escherichia Coli Toxin

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Jul 21
PMID 19617347
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

YafO is a toxin encoded by the yafN-yafO antitoxin-toxin operon in the Escherichia coli genome. Our results show that YafO inhibits protein synthesis but not DNA or RNA synthesis. The in vivo [35S]methionine incorporation was inhibited within 5 min after YafO induction. In in vivo primer extension experiments with two different mRNAs, the specific cleavage bands appeared 11-13 bases downstream of the initiation codon, AUG, 2.5 min after the induction of YafO. An identical band was also detected in in vitro toeprinting experiments when YafO was added to the reaction mixture containing 70 S ribosomes and the same mRNAs even in the absence of tRNA(f)(Met). Notably, this band was not detected in the presence of YafO alone, indicating that YafO by itself does not have endoribonuclease activity under the conditions used. The full-length mRNAs almost completely disappeared 30 min after YafO induction in in vivo primer extension experiments, consistent with Northern blotting analysis. Over 84% of [35S]methionine-tRNA(f)(Met) was released from the translation initiation complex at 5.43 microM YafO in vitro. We demonstrated that the 70 S ribosome peak significantly increased upon YafO induction, and when the 70 S ribosomes dissociated into 50 and 30 S subunits, YafO was found to be associated with 50 S subunits. These results demonstrate that YafO is a ribosome-dependent mRNA interferase inhibiting protein synthesis.

Citing Articles

Type II Toxin-Antitoxin Systems in .

Zhang H, Tao S, Chen H, Fang Y, Xu Y, Han A Infect Drug Resist. 2025; 18:1083-1096.

PMID: 40027916 PMC: 11869752. DOI: 10.2147/IDR.S501485.


YafN-YafO toxin-antitoxin system contributes to stress resistance and virulence of avian pathogenic Escherichia coli.

Chen Q, Sun Y, Xing Q, Li Z, Gao S, Gao Q Poult Sci. 2025; 104(2):104760.

PMID: 39754924 PMC: 11758553. DOI: 10.1016/j.psj.2024.104760.


Contribution of Toxin-Antitoxin Systems to Adherent-Invasive Pathogenesis.

Bustamante P, Ramos-Corominas M, Martinez-Medina M Microorganisms. 2024; 12(6).

PMID: 38930540 PMC: 11205521. DOI: 10.3390/microorganisms12061158.


Pangenome analysis of Shewanella xiamenensis revealed important genetic traits concerning genetic diversity, pathogenicity and antibiotic resistance.

Wang H, Xia F, Xia Y, Li J, Hu Y, Deng Y BMC Genomics. 2024; 25(1):216.

PMID: 38413855 PMC: 10898099. DOI: 10.1186/s12864-024-10146-z.


Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in Encoding .

Alobaidallah M, Garcia V, De Mets R, Wellner S, Thomsen L, Herrero-Fresno A Antibiotics (Basel). 2023; 12(6).

PMID: 37370312 PMC: 10295648. DOI: 10.3390/antibiotics12060993.


References
1.
Swaney S, Aoki H, Ganoza M, Shinabarger D . The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998; 42(12):3251-5. PMC: 106030. DOI: 10.1128/AAC.42.12.3251. View

2.
Sarmientos P, Sylvester J, Contente S, CASHEL M . Differential stringent control of the tandem E. coli ribosomal RNA promoters from the rrnA operon expressed in vivo in multicopy plasmids. Cell. 1983; 32(4):1337-46. DOI: 10.1016/0092-8674(83)90314-8. View

3.
Zhang Y, Zhu L, Zhang J, Inouye M . Characterization of ChpBK, an mRNA interferase from Escherichia coli. J Biol Chem. 2005; 280(28):26080-8. DOI: 10.1074/jbc.M502050200. View

4.
Aoki H, Ke L, Poppe S, Poel T, Weaver E, Gadwood R . Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes. Antimicrob Agents Chemother. 2002; 46(4):1080-5. PMC: 127084. DOI: 10.1128/AAC.46.4.1080-1085.2002. View

5.
Halegoua S, Hirashima A, Inouye M . Puromycin-resistant biosynthesis of a specific outer-membrane lipoprotein of Escherichia coli. J Bacteriol. 1976; 126(1):183-91. PMC: 233273. DOI: 10.1128/jb.126.1.183-191.1976. View